EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Solving an enigma: the BMP-9/10 axis as a key regulator of pulmonary vascular resilience

Christophe Guignabert iD, Marc Humbert iD

European Respiratory Journal · 07.09.2026 · 2600621

DOI: 10.1183/13993003.00621-2026 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Respiratory Journal, online erschienen am 07.09.2026. Verfasst von Christophe Guignabert und 1 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, INSERM UMR_S 1358, Pulmonary Hypertension: Pathophysiology and Therapeutic Innovation (HPPIT), and AP-HP, Department of Resp…. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Agence Nationale de la Recherche, Fondation pour la Recherche Médicale, Agence Régionale de Santé Île-de-France.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The circulating ligands bone morphogenetic protein (BMP)-9 and BMP-10 are emerging as dual regulators of pulmonary and systemic vascular biology. Acting through activin receptor-like kinase 1 (ALK1), BMP receptor type II (BMPRII) and endoglin receptor complexes, they maintain endothelial quiescence and vascular tone under physiological conditions. Yet, the same axis can turn pathogenic when its intensity, timing or cellular context are altered. We propose viewing BMP-9/10 not as a linear protective pathway but as a bimodal system in which both deficiency and hyperactivation disrupt vascular homeostasis, leading to distinct phenotypes such as obstructive pulmonary arterial remodeling in pulmonary arterial hypertension (PAH), intrapulmonary vasodilatation in hepatopulmonary syndrome (HPS), and arteriovenous shunting in hereditary haemorrhagic telangiectasia (HHT). The clinical success of sotatercept, an activin signaling inhibitor with partial BMP-ligand trap properties, underscores the translational potential of therapeutically “retuning” this pathway rather than globally enhancing it. Understanding when BMP-9/10 signaling protects and when it becomes pathogenic will be crucial for designing next-generation interventions that stabilize, instead of destabilize, pulmonary vascular integrity.

Autor:innen und Institutionen

  • Université Paris-Saclay, INSERM UMR_S 1358, Pulmonary Hypertension: Pathophysiology and Therapeutic Innovation (HPPIT), and AP-HP, Department of Respiratory and Intensive Care Medicine, French Pulmonary Hypertension Ref…

ORCID-Profile: Christophe Guignabert, Marc Humbert

Förderung

  • Agence Nationale de la Recherche
  • Fondation pour la Recherche Médicale
  • Agence Régionale de Santé Île-de-France

Zitieren

APA

Guignabert, C., & Humbert, M. (2026). Solving an enigma: the BMP-9/10 axis as a key regulator of pulmonary vascular resilience. European Respiratory Journal, 2600621. https://doi.org/10.1183/13993003.00621-2026

Vancouver

Guignabert C, Humbert M. Solving an enigma: the BMP-9/10 axis as a key regulator of pulmonary vascular resilience. European Respiratory Journal. 2026:2600621. doi:10.1183/13993003.00621-2026

BibTeX
@article{Guignabert2026,
  author = {Guignabert, Christophe and Humbert, Marc},
  title = {Solving an enigma: the BMP-9/10 axis as a key regulator of pulmonary vascular resilience},
  journal = {European Respiratory Journal},
  year = {2026},
  pages = {2600621},
  doi = {10.1183/13993003.00621-2026}
}
Kostenlos starten →